A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers
A Randomized, Double-blind, Vehicle-controlled, Dose-finding Multi-center, Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers With Androgenetic Alopecia
In the register
The register attaches this trial to FOL-005 (Follicum), currently at “Phase 2” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Completed
- Declared phase
- Phase 2
- Sponsor
- Follicum AB
- Participants (registry)
- 209
- Start
- June 2020
- Primary completion
- January 2021
- Study completion
- January 2021
- Last registry update
- March 2021
- Countries
- Germany
Conditions studied: Androgenetic Alopecia
Interventions: Topical formulation
Other trials of FOL-005
To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin
Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.